hims glp 1 review & Hers Stock Plummets. The Wegovy Shortage Is Over The Unraveling of Hims' GLP-1

Same-day appointments available.

Learn how to spot telogen effluvium, protect protein and nutrients, and use proven treatments to stop shedding and restart healthy growth on GLP-1s

It is given as an injection under the skin (subcutaneously), every 2 weeks or once a month

Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below:

For example, a large-scale retrospective study using data from the US Department of Veterans Affairs showed GLP-1 use to be associated with a reduced risk of 42 conditions in a diabetic population1